References
- VANE JR, BOTTING RM: The mode of action of anti-in- flammatory drugs. Postgrad. Med. J. (1990) 66\(Suppl. 4): S2–S17.
- LICH1ENSTEIN DR, SYNGAL S, WOLFE MM: b>Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword. Artbr. Rheum, (1995) 38:5–8.
- WALKER L, FROLICH JC: Renal prostaglandins and leuk-otrienes. Rev. Physiol. Biochem. Pharmacol. (1987) 107:1- 72.
- XIE W, ROBERTSON DL, SIMMONS DL: Mitogen-inducibleprostaglandin G/H synthase: anew target for nonsteroi-dal antiinflammatory drugs. Drug Dev . Res. (1992) 25:249–265.
- DAY RO: Variability in response to NSAIDs: what pro-gress? In: Variability in Response to Anti-Rheumatic Drugs. Brooks PM, Day RO, Graham GG, Williams KM (Eds.), Agents and Actions Suppl. 44. Birkhauser Verlag, Basel (1993):3–6.
- IIERBEI IL LG: b>Membrane pathways for drug/ion chan-nel interactions: molecular basis for pharmacoldnetic properties. Drug Dev. Res. (1994) 33:214-224.
- NEWMAN NM, LING RSM: Acetabular bone destructionrelated to non-steroidal anti-inflammatory drugs. Lan-cet(1985) 2:11–14.
- FRIES JF, SPITZ PW, WILLIAMS CA, BLOCH DA, SINGII G,HUI3ERT HB A toxicity index for comparison of side-ef-fects among different drugs. Arthr. Rheum. (1990) 33:121-130.
- HAYLLAR J, BJAILNASON I: NSAIDs, COX-2 inhibitors, andthe gut. Lancet (1995) 346:521-522.
- VANE JR, MITCHELL JA, APPLETON I, TOMLINSON A, 131S1-10P-BAILEY D, CROXTALL J, WILLOUGHBY DA: In-ducible isoforms of cyclo-oxygenase and nitric oxide synthase in inflammation. Proc. Natl. Acad. Set. USA (1994) 91:2046–2050.
- VANE JR, BOTTING RM: New insights into the mode ofaction of anti-inflammatory drugs. Inflamm. Res. (1995) 44:1–10.
- LC X, XIE W, REED D, BRADSHAW WS, SIMMONS DL: Nonsteroidal anti-inflammatory drugs cause apoptos is and induce cyclo-oxygenases in chicken embryo fi-broblasts. Proc. Natl. Acad. Sci. USA (1995) 82. In press. Michael J Parnham, Pamham Advisory Services, Von Guericke Alice 4, D-53125 Bonn, Germany.